Literature DB >> 23270686

HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: implications for the epitope structural features.

Karlen G Gazarian1, Yadira Palacios-Rodríguez, Tatiana G Gazarian, Leonor Huerta.   

Abstract

The crown region of the V3 loop in HIV-1 that contains the conserved amino acid sequence GPGR/G is known as the principal neutralizing determinant due to the extraordinary ability of antibodies to this region to neutralize the virus. To complement the existing peptide models of this epitope, we describe a family of 18 phage-displayed peptides, which include linear 12mer and constrained 7mer peptides that was selected by screening random libraries with serum from HIV-1 subtype B-infected patients. The 7mer constrained peptides presented two conserved amino acid sequences: PR-L in N-terminus and GPG in the C-terminus. On the basis of these peptides we propose a mimotope model of the V3 crown epitope in which the PR-L and GPG sequences represent the two known epitope binding sites. The GPG, has the same function as the V3 crown GPGR sequence but without the involvement of the "R" despite its being considered as the signature of the epitope in B-subtype viruses. The PR-L contains a proline not existing in the epitope that is postulated to induce kinks in the backbones of all peptides and create a spatial element mimicking the N-terminal conformationally variable binding site. Rabbit serum to these mimotopes recognized the V3 peptides and moderately decreased the fusion between HIV-1 Env- and CD4-expressing Jurkat cells. This study proposes the efficient generation by means of patient sera of V3 epitope mimics validated by interaction with the antibodies to contemporary viruses induced in patients. The serum antibody-selectable mimotopes are sources of novel information on the fine structure-function properties of HIV-1 principal neutralizing domain and candidate anti-HIV-1 immunogens.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23270686     DOI: 10.1016/j.molimm.2012.11.016

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

Review 1.  Current approaches to fine mapping of antigen-antibody interactions.

Authors:  W Mark Abbott; Melissa M Damschroder; David C Lowe
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

2.  Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.

Authors:  Anton N Chikaev; Anastasiya Yu Bakulina; Ryan C Burdick; Larisa I Karpenko; Vinay K Pathak; Alexander A Ilyichev
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 3.  Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.

Authors:  Kyriakos A Hassapis; Dora C Stylianou; Leondios G Kostrikis
Journal:  Viruses       Date:  2014-12-17       Impact factor: 5.048

4.  HIV-1 envelope glycoprotein variable loops are indispensable for envelope structural integrity and virus entry.

Authors:  Tingting Yuan; Jingjing Li; Mei-Yun Zhang
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

Review 5.  Oligopeptide m13 phage display in pathogen research.

Authors:  Jonas Kügler; Jonas Zantow; Torsten Meyer; Michael Hust
Journal:  Viruses       Date:  2013-10-16       Impact factor: 5.048

6.  The development of inovirus-associated vector vaccines using phage-display technologies.

Authors:  Zachariah Stern; Dora C Stylianou; Leondios G Kostrikis
Journal:  Expert Rev Vaccines       Date:  2019-09-08       Impact factor: 5.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.